A 31-year-old female, G2P1, at 10 weeks gestation presents for her first prenatal visit. She works as an emergency department nurse. She reports a history of an anaphylactic reaction to baker's yeast that resulted in intubation during her teenage years. Her childhood vaccination records were lost in a house fire, and she is unsure of her complete immunization history, although she notes receiving an annual influenza vaccine. Laboratory testing reveals she is non-immune to both rubella and hepatitis B. Which of the following immunization actions are appropriate for this patient during the course of her current pregnancy? (Select all that apply)
- Administer the inactivated influenza vaccine at today's visitAnswer
- Administer the tetanus, diphtheria, and acellular pertussis (Tdap) vaccine between 27 and 36 weeks gestationAnswer
- CAdminister the recombinant hepatitis B vaccine series starting at today's visit
- DAdminister the measles, mumps, and rubella (MMR) vaccine at today's visit
- EAdminister the human papillomavirus (HPV) vaccine series starting at today's visit
- FAdminister the 20-valent pneumococcal conjugate vaccine (PCV20) at today's visit
Answer
The appropriate actions are to administer the inactivated influenza vaccine at today's visit and administer the Tdap vaccine between 27 and 36 weeks gestation.
Immunization during pregnancy focuses on safely protecting both the mother and the fetus. The inactivated influenza vaccine is highly recommended in any trimester to prevent severe maternal respiratory illness, which is more common during pregnancy. The Tdap vaccine is universally recommended during every pregnancy, optimally between 27 and 36 weeks gestation. This specific timing facilitates the maximum transfer of maternal IgG antibodies across the placenta, effectively protecting the newborn from severe pertussis before they are old enough to receive their own primary DTaP series.
Step-by-Step Solution
Key Concept
Immunization management during pregnancy requires balancing maternal and fetal benefit with theoretical risks: inactivated influenza and Tdap are universally recommended, while live vaccines (MMR) and vaccines containing severe allergens (baker's yeast in Hepatitis B) are absolutely contraindicated.
Estimated Time:1m 30s